Julián M.T., Ballesta S., Pera G., Pérez-Montes de Oca A., Soldevila B., Caballería L., Morillas R., Expósito C., Martínez–Escudé A., Puig-Domingo M., Franch-Nadal J., Torán P., Cusi K., Julve J., Mauricio D., Alonso N.. Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: A population-based study. Frontiers in Endocrinology. 2023; 13DOI:10.3389/fendo.2022.1051958. PMID:36714592. IF:3.900(Q2/3D).

Battelino T., Alexander C.M., Amiel S.A., Arreaza-Rubin G., Beck R.W., Bergenstal R.M., Buckingham B.A., Carroll J., Ceriello A., Chow E., Choudhary P., Close K., Danne T., Dutta S., Gabbay R., Garg S., Heverly J., Hirsch I.B., Kader T., Kenney J., Kovatchev B., Laffel L., Maahs D., Mathieu C., Mauricio D., Nimri R., Nishimura R., Scharf M., Del Prato S., Renard E., Rosenstock J., Saboo B., Ueki K., Umpierrez G.E., Weinzimer S.A., Phillip M.. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes & Endocrinology. 2023; 11(1)DOI:10.1016/S2213-8587(22)00319-9. PMID:36493795. IF:44.000(Q1/1D).

Ampudia-Blasco F.J., Ugarte-Abasolo E., Chico A., García-Alemán J., Galan-Barroso M.. Spanish Consensus on the Use of isCGM in the Management of Patients With Insulin Therapy: The MONITOR Project. Journal Of Diabetes Science And Technology. 2023; 17(5)DOI:10.1177/19322968221087270. PMID:35466722. IF:(Q/D).

Rojo-López M.I., Bermúdez-López M., Castro E., Farràs C., Torres G., Pamplona R., Lecube A., Valdivielso J.M., Fernández E., Julve J., Castelblanco E., Franch-Nadal J., Alonso N., Granado-Casas M., Mauricio D., Miquel E., Ortega M., Barbé F., González J., Barril S., Sánchez-de-la-Torre M., Portero-Otín M., Jové M., Hernández M., Rius F., Godoy P., Alonso M.M.. Low adherence to the Mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort. ATHEROSCLEROSIS. 2023; 380DOI:10.1016/j.atherosclerosis.2023.117191. PMID:37586219. IF:4.900(Q1/2D).